Patent assignee · FR · COMPANY

INSTITUT REGIONAL DU CANCER DE MONTPELLIER (ICM)

🏢 View company profile →
16Patents
16Active
16Granted
49Portfolio score

Filing activity: Feb 26, 2013 → Jun 23, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US11478486B2 Association of actives for treating prostate cancer Human Necessities 0 Active
US10704104B2 Methods for screening a subject for a cancer Chemistry; Metallurgy 0 Active
US11821044B2 Methods for screening a subject for a cancer Chemistry; Metallurgy 0 Active
US10196455B2 Neuregulin allosteric anti-HER3 antibody Chemistry; Metallurgy 0 Active
US10398774B2 Human monoclonal antibodies against AXL Human Necessities 0 Active
US9931416B2 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer Chemistry; Metallurgy 0 Active
US11149314B2 Methods for determining the quality of an embryo Chemistry; Metallurgy 0 Active
US10001491B2 Method for determining radiosensitivity Physics 0 Active
US10526415B2 Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor Chemistry; Metallurgy 0 Active
US11814686B2 Method for screening and treating a subject for a cancer Chemistry; Metallurgy 0 Active
US9932410B2 Human neutralizing anti-kit antibodies and uses thereof Chemistry; Metallurgy 0 Active
US11001634B2 Anti-human-HER3 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US12054550B2 Bispecific antibodies targeting EGFR and HER2 Chemistry; Metallurgy 0 Active
US11186635B2 Monoclonal antibodies binding to the CD160 transmembrane isoform Chemistry; Metallurgy 0 Active
US10758615B2 Human monoclonal antibodies against orexin receptor type 1 Chemistry; Metallurgy 0 Active
US9687552B2 Association of poly(N-acryloylglycinamide) with at least one active principle Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.